Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;126(1):91-99.
doi: 10.1038/s41416-021-01539-y. Epub 2021 Oct 29.

The use of biomarkers and HPV genotyping to improve diagnostic accuracy in women with a transformation zone type 3

Affiliations

The use of biomarkers and HPV genotyping to improve diagnostic accuracy in women with a transformation zone type 3

Kristyn Manley et al. Br J Cancer. 2022 Jan.

Abstract

Background: Twenty percent of women referred to colposcopy have a type 3 transformation zone-where colposcopic assessment for high-grade dysplasia (CIN2+) is not possible. This study examines the effectiveness of HPV biomarkers and genotyping in combination with techniques that sample an endocervical TZ.

Methods: A prospective diagnostic accuracy study. Women booked for large-loop excision (LLETZ) with squamous dyskaryosis, high-risk HPV and a TZ3 were recruited. Immediately prior to LLETZ samples were collected for p16/Ki-67 dual-stained cytology, HPV genotyping and H&E, p16- and Ki-67-stained endocervical curettings.

Results: In women with low-grade screening (n = 64), 35.9% had CIN2+; dual-stained cytology had the greatest effect on the PPV of routine screening (76.1% vs 35.9%) and perfectly predicted the absence of CIN2+. In women with a high-grade screening result (n = 37); 75.6% had CIN2+ and dual-stained curettings improved the PPV (96.5 vs 75.6%).

Conclusions: With high-grade screening and a TZ3, LLETZ appears safest as three quarters have CIN2+ . Women with low-grade screening and a TZ3 have a twofold increased risk of CIN2+ when compared to women where the TZ is visible. The use of dual-stained cytology may help identify those women who can be safely offered surveillance and those who require treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Flowchart of study recruitment.
Incorporates the number of women who had a LLETZ treatment within the department over the recruitment period, those eligible for participation in the study, total recruited, number of adequate samples and complete datasets.
Fig. 2
Fig. 2. Endocervical curettings with H&E, Ki-67 and p16 immununostains.
Referral and index cytology reported as BNC. HPV 33 & 35 on genotyping. Dual-stain positive. Curettings fragmented. CIN of indefinable grade on H&E (a), full-thickness Ki-67 staining (b), strongly stained p16 (c). The final diagnosis for the index curettings was CIN2+. LLETZ reported as CIN3.
Fig. 3
Fig. 3. Dual-staining (p16/Ki-67) of the cervical screening cytology samples.
Referral and index cytology reported as BNC; increased nuclei:cytoplasmic ratio but clumping of the cells reduced differentiation of reactive cells from dyskaryotic on the index cytology (a). HPV 16 and 33 on genotyping. Dual-staining was reported as positive (b). CIN2 was reported in the LLETZ histology.

References

    1. Bruni L, Diaz M, Castelsague X, Ferrer E, Bosch F, de Sanjose S, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202:1789–99. doi: 10.1086/657321. - DOI - PubMed
    1. Kelly RS, Patnick J, Kitchener HC, Moss SM. HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. Br J Cancer. 2011;105:983–8. doi: 10.1038/bjc.2011.326. - DOI - PMC - PubMed
    1. Massad LS, Einstein M, Huh W, Katki H, Kinney W, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Trac Dis. 2013;17:S1–27. doi: 10.1097/LGT.0b013e318287d329. - DOI - PubMed
    1. Public Health England. NHS CSP Publication 20. Cervical Screening: programme and colposcopy management. Third Edition (14th March 2016). Cervical screening: programme and colposcopy management - GOV.UK (www.gov.uk). Accessed 26 October 2021.
    1. Castanon A, Landy R, Brocklehurst P, Evans H, Peebles D, Singh N, et al. Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study. BMJ. 2014;349:g6223. doi: 10.1136/bmj.g6223. - DOI - PMC - PubMed

Publication types

MeSH terms